SCHEMBL2914478

SCHEMBL2914478

NCn1cc2ccccc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.36
HDAC8 Q9BY41 1/20 0.35
MAPT P10636 4/20 0.35
ALDH1A1 P00352 3/20 0.34
HPGD P15428 2/20 0.34
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
GLA P06280 1/20 0.34
ACHE P22303 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NOS2 P35228 2/20 0.34
NCF1 P14598 1/20 0.34
BACE1 P56817 1/20 0.34
PARP1 P09874 1/20 0.33
NQO2 P16083 1/20 0.33
UBE2T Q9NPD8 1/20 0.33
ASIC3 Q9UHC3 1/20 0.33
TLR8 Q9NR97 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9674453 0.84 TLR8 (0.37) SLC6A2HDAC8MAPTALDH1A1HPGD
Hydrochloric Acid SCHEMBL10682979 0.82 TLR8 (0.36) SLC6A2HDAC8MAPTSLC6A4SLC6A3
SCHEMBL29541132 0.80 PDE10A (0.39) SLC6A2HDAC8MAPTALDH1A1HPGD
SCHEMBL17274873 0.79 SLC6A2 (0.40) SLC6A2HDAC8MAPTALDH1A1HPGD
SCHEMBL5764690 0.79 SLC6A2 (0.43) SLC6A2HDAC8MAPTALDH1A1HPGD
SCHEMBL11604153 0.79 HDAC8 (0.38) SLC6A2HDAC8MAPTALDH1A1HPGD
SCHEMBL19475067 0.76 PARP1 (0.51) HDAC8PARP1
SCHEMBL16836646 0.76 ATM (0.41) SLC6A2HDAC8MAPTALDH1A1HPGD
SCHEMBL10123647 0.76 SLC6A2 (0.44) SLC6A2MAPTALDH1A1HPGDGLA
SCHEMBL8768009 0.76 SLC6A2 (0.36) SLC6A2HDAC8MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016044313-A1 METHODS AND COMPOSITIONS FOR THE REMOVAL OF ALDEHYDE ADDUCTS AND CROSSLINKS FROM BIOMOLECULES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2016-03-24 WO disclosed
EP-1931641-B1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI SCHERING CORP (US) 2010-08-25 EP disclosed
US-20100143384-A1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS MALLAMS ALAN K 2010-06-10 US disclosed
US-20100137326-A1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION 2010-06-03 US disclosed
US-7700773-B2 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2010-04-20 US disclosed
CN-101300233-A Aza-fused cyclin-dependent kinase inhibitors SCHERING CORP (US) 2008-11-05 CN disclosed
EP-1931641-A2 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI SCHERING CORPORATION (US) 2008-06-18 EP disclosed
US-20070066621-A1 Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2h-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors SCHERING CORPORATION 2007-03-22 US disclosed
WO-2007032936-A2 AZAFUSED CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100143384-A1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS CDK4, CDK2, CDK5 SLC6A2 4722/4885HDAC8 998/4885MAPT 3770/4885
US-20100137326-A1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS CDK4, CDK2, CDK5 SLC6A2 4722/4885HDAC8 998/4885MAPT 3770/4885
US-20070066621-A1 Novel 4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2h-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors CDK4, CDK2, CDK5 SLC6A2 4722/4885HDAC8 998/4885MAPT 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.